(4-((Trimethylsilyl)ethynyl)phenyl)boronic acid, 95.0%, 100mg

6-(Acetylamino)hexanoic acid, 97.0%, 5g

GC capillary column ROTI®Cap-1701, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)

(2S,3S)-2-Methylazetidin-3-ol hydrochloride, 97%, 100mg

5-Bromo-2-(trifluoromethyl)pyrimidine, 96.0%, 25g

(S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid hydrochloride, 95.0%, 1g

1-(2-Hydroxy-4-trifluoromethyl-phenyl)-ethanone, 97%, 1g

1-(2-Ethoxy-2-oxoethyl)pyridin-1-ium bromide, 95.0%, 25g

4-METHOXY-4-METHYLCYCLOHEXANE-1-CARBALDEHYDE, 95.0%, 250mg

2-(4-Chloro-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

N-Methyl-N-tetrahydro-2H-pyran-4ylamine, 97.0%, 10g

2'-Methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxylic acid, 98%, 250mg

2,6-Dichloro-4-(trifluoromethyl)pyridine, 98.0%, 25g